Search for: "Pfizer, Inc. (Pfizer)"
Results 581 - 600
of 1,505
Sorted by Relevance
|
Sort by Date
1 Apr 2008, 2:16 am
Teva Pharmaceuticals USA, Inc. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
15 Nov 2011, 3:58 pm
Other potential acquirers could include larger pharmaceutical companies like Celgene Corp., Pfizer Inc. and Teva Pharmaceuticals, which have dabbled in stem cells without making major investments. [read post]
12 Aug 2019, 8:05 am
In the third decision, Pfizer Inc. v. [read post]
22 Aug 2012, 6:09 am
Pfizer Inc. tested the new trend last year and now offers copay coupons that can bring insured patients six of its medicines for as little as $4 a month each. [read post]
25 Jul 2012, 2:21 pm
Pfizer, Inc., 2012 WL 2970627 (D. [read post]
18 Jan 2015, 4:30 am
Standard of review from Minister of Health is correctness Pfizer Canada v. [read post]
25 Jul 2008, 10:51 am
Pfizer and the other defendants in the Mirapex litigation are seeking a bifurcated trial plan. [read post]
13 Jan 2010, 5:00 am
Another "grant and hold" case, Pfizer v. [read post]
6 Jan 2014, 6:45 am
(TEVA) of Petach Tikva, Israel, and Pfizer(PFE) Inc. of New York are working with stem-cell researchers on new therapies. [read post]
18 Apr 2021, 5:21 pm
Recent Headlines in the IP World: Kim Yun-Mi: BMS, Pfizer Win Final Suit for Eliquis Patent (Source: Korea Biomedical Review) David Hyman: Rakovina Therapeutics Inc. [read post]
6 Jun 2016, 12:21 pm
Shore, Vice President and Chief Ombudsman, CO-OP®, Office of the Ombudsman, Pfizer Inc.; Joan Waters, University Ombuds Officer, Columbia University; James Hurst, Agency Staff Attorney, NYC Department of Consumer Affairs; Nancy Deering, Newark Public Schools and IOAProgram Description: Explore the impact of the ombuds role in advancing conflict resolution and ADR. [read post]
15 May 2021, 6:00 pm
Bashar Malkawi: Royalty Rate Determination in Patent Infringement Cases: The U.S. and China Compared (Source: SSRN) New Job Postings on Patently-O: Boston Scientific Clark+Elbing LLP Warner Norcross + Judd LLP – Patent Associate Attorney Warner Norcross + Judd LLP – Patent Agent Weaver Austin Villeneuve & Sampson LLP Murphy, Bilak & Homiller PLLC (MBH) McNeill Baur Faegre Drinker ALG Intellectual Property, LLC PTC Therapeutics Inc Miller & Martin Workman… [read post]
4 Feb 2021, 1:17 pm
Here are the nominees along links to any information published on the Ombuds Blog:Roy Baroff, CO-OP (incumbent) — Faculty & Staff Ombuds, North Carolina State University;Suzanne Diviney, CO-OP (incumbent) — Vice President, Office of the Ombuds Lead, Pfizer Inc. [read post]
20 Jan 2008, 10:42 pm
Chantix is classed as a selective nicotinic acetylcholine receptor partial agonist, and is the first smoking cessation drug that is not based on nicotine to come out in the last 10 years.Pfizer Inc. strengthened the warning for iChantix recently, and warned medical professionals to be on the lookout for for abnormal behavior after the shooting death of a rock musician using the drug led to added reports of side effects.A possible link between the drug and reports of agitation, depressed… [read post]
31 Jul 2011, 10:35 pm
Director, Emerging Markets Policy – Pfizer Inc., New York, NYDirector/ Sr. [read post]
11 Jun 2007, 3:43 am
(order) (06/08/2007, non-precedential): Mylan moved for summary reversal of the judgment and amended judgment of the district court, of which Pfizer opposes; in a separate case (Pfizer, Inc. v. [read post]
8 Nov 2010, 7:35 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
10 May 2010, 10:37 am
Quigg, 8 U.S.P.Q.2d 1491 (D.D.C.1988), aff’d 876 F.2d 99 U.S.P.Q.2d 1869 (Fed.Cir.1989), and Pfizer Inc. v. [read post]
